Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Will Offer Epoch Gene Expression Products

NEW YORK, Nov. 5-Qiagen will market and sell products that use Epoch Bioscience's MGB Eclipse Probe gene expression chemistry, the companies said today.

 

Epoch will supply components exclusively to Qiagen, which will begin selling custom and standard probe systems based on the company's technology in early 2003.

 

Qiagen has a non-exclusive license to the components, and has pledged to reach certain sales goals as part of the agreement.

 

Epoch will receive access fees and royalties through the deal.

 

The MGB Eclipse Probe includes specialized software, proprietary dye and quencher technologies. It can be used for routine sequence analysis as well as discovery of splice variants and "problematic SNPs," the company says.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.